Tag Archives: J&J’s

Pfizer, Astellas’ Xtandi matches J&J’s rival Erleada with new prostate cancer nod

Pfizer and Astellas’ stalwart prostate cancer med Xtandi has watched as Johnson & Johnson’s challenger, Erleada, picked up the lead in the metastatic, castration-sensitive form of the disease. But now Xtandi is ready to take on its familiar foe with a new green light of its own. The FDA on Monday approved Xtandi as a… Read More »

Judge denies J&J’s request to transfer 2,400 talc lawsuits to federal court

Containers of Johnson’s baby powder made by Johnson and Johnson are displayed on a shelf on July 13, 2018 in San Francisco, California. Justin Sullivan | Getty Images A federal judge on Friday denied Johnson & Johnson‘s request to transfer about 2,400 lawsuits over its talc-based baby powder to a district court in Delaware, sending… Read More »